# The Immune Modulation of Bilateral Paravertebral Block and Propofol in Spine Surgery.

> **NCT03437213** · NA · COMPLETED · sponsor: **Alaa Mazy Mazy** · enrollment: 40 (actual)

## Conditions studied

- Immune Suppression

## Interventions

- **DRUG:** Total intravenous anesthesia group
- **DRUG:** Total intravenous plus block group

## Key facts

- **NCT ID:** NCT03437213
- **Lead sponsor:** Alaa Mazy Mazy
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2019-08-25
- **Final completion:** 2020-09-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03437213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03437213, "The Immune Modulation of Bilateral Paravertebral Block and Propofol in Spine Surgery.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03437213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*